Regression model (1) | Regression model (2) | Regression model (3) | ||||
---|---|---|---|---|---|---|
β | p Value | β | p Value | β | p Value | |
Baseline measures of inflammation | ||||||
MRI bone marrow oedema | 0.17 | 0.28 | 0.26 | 0.06 | ||
MRI synovitis | 0.19 | 0.23 | 0.34 | 0.02 | ||
ESR | ||||||
Anti-CCP positivity | 0.28 | 0.04 | ||||
Female | −0.13 | 0.32 | −0.17 | 0.21 | ||
Age | −0.07 | 0.62 | −0.02 | 0.87 | ||
R2=0.09, aR2=0.05 | R2=0.18, aR2=0.11 | R2=0.38, aR2=0.32 | ||||
1-Year time-integrated measures of inflammation (AUC) | ||||||
MRI bone marrow oedema | 0.28 | 0.05 | 0.35 | 0.01 | ||
MRI synovitis | 0.27 | 0.06 | 0.47 | <0.001 | ||
ESR | 0.29 | 0.03 | 0.35 | 0.004 | ||
Anti-CCP positivity | 0.30 | 0.02 | ||||
Female | −0.01 | 0.94 | −0.12 | 0.30 | ||
Age | −0.19 | 0.13 | −0.13 | 0.27 | ||
R2=0.20, aR2=0.17 | R2=0.09, aR2=0.04 | R2=0.26, aR2=0.20 |
anti-CCP, anti-citrullinated protein antibodies; aR2, fraction of explained variance adjusted for the number of included variables; ESR, erythrocyte sedimentation rate; R2, fraction of explained variance.